Termination of the Proceedings | Oct 14, 2015 | PAPER | BOARD |
Joint Motion to Terminate | Oct 9, 2015 | PAPER | PATENT OWNER |
Joint Request to Treat Settlement Agreement as Business Confidential | Oct 9, 2015 | PAPER | PATENT OWNER |
Exhibit List | Oct 9, 2015 | PAPER | PATENT OWNER |
Exhibit 2001 | Oct 9, 2015 | EXHIBIT | PATENT OWNER |
Notice of Accepting Corrected Petition | Jul 28, 2015 | PAPER | BOARD |
Power of Attorney | Jul 24, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Power of Attorney | Jul 24, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Related Matters | Jul 24, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Cover Letter re Corrected Petition | Jul 21, 2015 | PAPER | PETITIONER |
Corrected Petition for Inter Partes Review of Claims 22-27 and 30 of U.S. Patent No. 8,729,094 | Jul 21, 2015 | PAPER | PETITIONER |
Notice of Filing Date Accorded to Petition and Notice of Defective Petition | Jul 17, 2015 | PAPER | BOARD |
Petition for IPR Review of Claims 22-27 and 30 of US Patent No. 8,729,094 | Jul 3, 2015 | PAPER | PETITIONER |
Transmittal Letter re Exhibits | Jul 3, 2015 | PAPER | PETITIONER |
Power of Attorney | Jul 3, 2015 | PAPER | PETITIONER |
U.S. Patent No. 8,729,094 | Jul 3, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. 7,947,724 | Jul 3, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. 7,947,725 | Jul 3, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. 7,960,424 | Jul 3, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. 8,598,219 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Complaint for Patent Infringement 14 cv 04274 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Complaints for Patent Infringement 11 cv 03962 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Serial No. 13/902,132 Final Rejection | Jul 3, 2015 | EXHIBIT | PETITIONER |
Serial No. 13/902,132, Amendment After Final | Jul 3, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. 5,202,333 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Eglen, Pharmacological characterization of RS 25259 197 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Chelly, Oral RS 25259 Prevents Postoperative Nausea and Vomiting Following Laparoscopic Surgery | Jul 3, 2015 | EXHIBIT | PETITIONER |
Gralla, Recommendations for the Use of Antiemetics Evidence Based, Clinical Practice Guidelines | Jul 3, 2015 | EXHIBIT | PETITIONER |
Gibson, Parenteral Dosage Forms | Jul 3, 2015 | EXHIBIT | PETITIONER |
Zofran In PDR | Jul 3, 2015 | EXHIBIT | PETITIONER |
Kytril In PDR | Jul 3, 2015 | EXHIBIT | PETITIONER |
Anzemet - In PDR | Jul 3, 2015 | EXHIBIT | PETITIONER |
Gaia Piraccini, Journal of the American Society of Hematology, 350b (Nov. 16, 2001) | Jul 3, 2015 | EXHIBIT | PETITIONER |
Tang, The Efficacy of RS 25259 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Lauri P. Cohen, Many Medicines Are Potent Years Past Expiration Date | Jul 3, 2015 | EXHIBIT | PETITIONER |
Declaration of William McGuire, M.D. | Jul 3, 2015 | EXHIBIT | PETITIONER |
William McGuire curriculum vitae | Jul 3, 2015 | EXHIBIT | PETITIONER |
Declaration of David G. Frame, Pharm.D. | Jul 3, 2015 | EXHIBIT | PETITIONER |
David G. Frame curriculum vitae | Jul 3, 2015 | EXHIBIT | PETITIONER |
Tr. transcript Dr. Kirsch - June 5, 2015 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Tr. transcript Dr. Candiotti - June 10, 2015 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Gandara et al., Consensus Proposal | Jul 3, 2015 | EXHIBIT | PETITIONER |
Tr. transcript Dr. Frame direct | Jul 3, 2015 | EXHIBIT | PETITIONER |
Tr. transcript Dr. Candiotti direct | Jul 3, 2015 | EXHIBIT | PETITIONER |
Tr. Transcript Dr. Frame direct | Jul 3, 2015 | EXHIBIT | PETITIONER |
FDA - Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers | Jul 3, 2015 | EXHIBIT | PETITIONER |
Tr. transcript Dr. Candiotti direct | Jul 3, 2015 | EXHIBIT | PETITIONER |
January 16, 2002 Helsinn Press Release | Jul 3, 2015 | EXHIBIT | PETITIONER |
October 3, 2001 Helsinn Press Release | Jul 3, 2015 | EXHIBIT | PETITIONER |
April 10, 2001 Helsinn Press Release | Jul 3, 2015 | EXHIBIT | PETITIONER |
Kibbe, Handbook of Pharmaceutical Excipients | Jul 3, 2015 | EXHIBIT | PETITIONER |
U.S. Patent No. 9,066,980, June 30, 2015 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Serial No. 13/902,132 Official Action, Aug. 8, 2013 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Serial No. 13/902,182 Applicants Amendment and Response to Office Action | Jul 3, 2015 | EXHIBIT | PETITIONER |
Declaration of Dr. Patrick P. DeLuca | Jul 3, 2015 | EXHIBIT | PETITIONER |
Curriculum Vitae of Dr. Patrick P. DeLuca | Jul 3, 2015 | EXHIBIT | PETITIONER |
Patrick P. DeLuca and James C. Boylan, 5 Formulation of Small Volume Parenterals | Jul 3, 2015 | EXHIBIT | PETITIONER |
Tr. transcript Dr. Amidon direct | Jul 3, 2015 | EXHIBIT | PETITIONER |
Brown, The Effectiveness of a Single Intravenous Dose of Ondansetron | Jul 3, 2015 | EXHIBIT | PETITIONER |
Helsinn Healthcare S.A. v. Dr. Reddys Laboratories, Ltd. | Jul 3, 2015 | EXHIBIT | PETITIONER |
Tr. transcript Dr. Amidon direct | Jul 3, 2015 | EXHIBIT | PETITIONER |
Tr. transcript Dr. Candiotti cross-examination | Jul 3, 2015 | EXHIBIT | PETITIONER |
Prosecution History of U.S. Patent No. 7,947,724 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Mikawa, Optimal Dose of Granisetron for Prophylaxis Against Postoperative Emesis After Gynecological Surgery | Jul 3, 2015 | EXHIBIT | PETITIONER |
Avis - 2 Parental Drug Administration Routes, Precautions, Problems, Complications | Jul 3, 2015 | EXHIBIT | PETITIONER |
Reproduction of Figure 5 of Eglen Exh.1011, at 863 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Reproduction of Figure 6a of Eglen Exh.1011, at 863 | Jul 3, 2015 | EXHIBIT | PETITIONER |
Dose response curves for Chelly (Exh.1012) and Tang (Exh.1019) | Jul 3, 2015 | EXHIBIT | PETITIONER |
Approved KYTRIL Label, Aug. 16, 2002 | Jul 3, 2015 | EXHIBIT | PETITIONER |
R.E. Leak and J.D. Woodford, Pharmaceutical Development of Ondansetron Injection | Jul 3, 2015 | EXHIBIT | PETITIONER |